SEC filings · customer concentration

Who depends on Medicaid

4 listed suppliers report Medicaid as a customer worth 10% or more of their revenue, led by PACS Group at 41%.

0major customers now
—of revenue from them
4listed suppliers depending on it
2017–2026years covered
Free

Get an email when Medicaid's customer concentration changes

When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.

Suppliers that depend on Medicaid

Listed companies whose annual report names Medicaid as a customer worth 10% or more of their revenue. If Medicaid cuts orders or switches supplier, these are the companies that feel it.

SupplierIts revenue from this companyChange vs prior yearHistoryLatest filing
PACS GroupPACS41%from 40%FY 2023: 38%FY 2024: 40%FY 2025: 41%3 yearsFY 2025 · filed 27 Feb 2026
Ensign GroupENSG40%from 40%FY 2018: 39%FY 2019: 40%FY 2020: 38%FY 2021: 39%FY 2022: 39%FY 2023: 39%FY 2024: 40%FY 2025: 40%8 yearsFY 2025 · filed 4 Feb 2026
Aveanna Healthcare HoldingsAVAH23%from 24%FY 2019: 29%FY 2021: 27%FY 2022: 22%FY 2023: 22%FY 2024: 24%FY 2026: 23%7 yearsFY 2026 · filed 19 Mar 2026
Pennant GroupPNTG13%from 13%FY 2017: 12%FY 2018: 13%FY 2019: 14%FY 2020: 14%FY 2021: 13%FY 2022: 13%FY 2023: 14%FY 2024: 13%FY 2025: 13%9 yearsFY 2025 · filed 26 Feb 2026

Formerly disclosed

SupplierIts revenue from this companyChange vs prior yearHistoryLatest filing
Viemed HealthcareVMD2%last FY 2023FY 2019: 8%FY 2020: 9%FY 2021: 9%FY 2022: 9%FY 2023: 2%5 yearsFY 2023 · filed 6 Mar 2024

About this data

US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.

All companies · Latest dependency shifts · Bulk data and API